CWA
COLL icon

Clearview Wealth Advisors’s Collegium Pharmaceutical COLL Stock Holding History

Clearview Wealth Advisors’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-147
Closed -$3.16K – 213
2023
Q2 		$3.16K Sell
147
-28,920
-99% -$657K ﹤0.01% 480
2023
Q1 		$697K Buy
+29,067
New +$771K 0.71% 42

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Clearview Wealth Advisors's COLL Position: Q3 2023 in Review

Clearview Wealth Advisors sold out of Collegium Pharmaceutical (COLL) in Q3 2023, closing a stake of 147 shares — an estimated $3.16K sold.

Clearview Wealth Advisors first reported a position in COLL in Q1 2023 and held it in 2 quarters. The position peaked at $697K in Q1 2023. 174 funds tracked by Wall St. Rank hold COLL as of Q3 2023.

  • Clearview Wealth Advisors reported no remaining Collegium Pharmaceutical position as of Q3 2023 after selling out during the quarter.
  • Clearview Wealth Advisors sold 147 Collegium Pharmaceutical shares in Q3 2023, an estimated $3.16K.
  • Clearview Wealth Advisors first reported a position in Collegium Pharmaceutical in Q1 2023 and held it in 2 quarters.
  • Clearview Wealth Advisors's Collegium Pharmaceutical position peaked at $697K in Q1 2023.
  • 174 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2023.

Based on Clearview Wealth Advisors's 13F filing for Q3 2023, filed 30 Oct 2023.